V. Avesani

Human antibody response to Clostridium difficile toxin A in relation to clinical course of infection

Michel Warny, J P Vaerman, V. Avesani et al. · Infection and Immunity · 1994 · 231 citations · Full text

Serum Immunoglobulin, Immunology, Gastroenterology +16

Serogroup F strains of Clostridium difficile produce toxin B but not toxin A

C. Depitre, M. Delmee, V. Avesani et al. · Journal of Medical Microbiology · 1993 · 95 citations

Microbial Toxin, Medical Microbiology, Toxinology +13

Description of Chryseobacterium anthropi sp. nov. to accommodate clinical isolates biochemically similar to Kaistella koreensis and Chryseobacterium haifense, proposal to reclassify Kaistella koreensis as Chryseobacterium koreense comb. nov. and emended description of the genus Chryseobacterium

Peter Kämpfer, Mario Vaneechoutte, N. Lodders et al. · INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY · 2009 · 88 citations

Bacteriology, Molecular Biology, Biosynthesis +19

Comparison of serogrouping and polyacrylamide gel electrophoresis for typing Clostridium difficile

Michel Delmée, Yves Laroche, V. Avesani et al. · Journal of Clinical Microbiology · 1986 · 80 citations · Full text

Typing Scheme, Antimicrobial Susceptibility, Health Sciences +14

Epidemiology and prevention ofClostridium difficile infections in a leukemia unit

Michel Delmée, Bernard Vandercam, V. Avesani et al. · European Journal of Clinical Microbiology & Infectious Diseases · 1987 · 79 citations

Preventive Medicine, Antimicrobial Susceptibility, Antibiotics +10